These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9505993)

  • 21. Disposition and antimuscarinic effects of the urinary bladder spasmolytics propiverine: influence of dosage forms and circadian-time rhythms.
    May K; Westphal K; Giessmann T; Wegner D; Adam U; Lerch MM; Oertel R; Warzok RW; Weitschies W; Braeter M; Siegmund W
    J Clin Pharmacol; 2008 May; 48(5):570-9. PubMed ID: 18319360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, open-label, two-period, crossover bioavailability study of two oral formulations of tacrolimus in healthy Korean adults.
    Park K; Kim YS; Kwon KI; Park MS; Lee YJ; Kim KH
    Clin Ther; 2007 Jan; 29(1):154-62. PubMed ID: 17379055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced oral absorption of paclitaxel in a novel self-microemulsifying drug delivery system with or without concomitant use of P-glycoprotein inhibitors.
    Yang S; Gursoy RN; Lambert G; Benita S
    Pharm Res; 2004 Feb; 21(2):261-70. PubMed ID: 15032307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin.
    Choi JS; Piao YJ; Kang KW
    Arch Pharm Res; 2011 Apr; 34(4):607-13. PubMed ID: 21544726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement of peroral absorption of cyclosporine A by microemulsions.
    Ritschel WA; Adolph S; Ritschel GB; Schroeder T
    Methods Find Exp Clin Pharmacol; 1990 Mar; 12(2):127-34. PubMed ID: 2319836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation.
    Schultz KR; Nevill TJ; Balshaw RF; Toze CL; Corr T; Currie CJ; Strong DK; Keown PA
    Bone Marrow Transplant; 2000 Sep; 26(5):545-51. PubMed ID: 11019845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation.
    Mueller EA; Kovarik JM; van Bree JB; Tetzloff W; Grevel J; Kutz K
    Pharm Res; 1994 Feb; 11(2):301-4. PubMed ID: 8165192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833.
    van Asperen J; van Tellingen O; Sparreboom A; Schinkel AH; Borst P; Nooijen WJ; Beijnen JH
    Br J Cancer; 1997; 76(9):1181-3. PubMed ID: 9365166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia.
    Gruber A; Björkholm M; Brinch L; Evensen S; Gustavsson B; Hedenus M; Juliusson G; Löfvenberg E; Nesthus I; Simonsson B; Sjo M; Stenke L; Tangen JM; Tidefelt U; Udén AM; Paul C; Liliemark J
    Leuk Res; 2003 Apr; 27(4):323-8. PubMed ID: 12531223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new microemulsion formulation of cyclosporin: pharmacokinetic and clinical features.
    Friman S; Bäckman L
    Clin Pharmacokinet; 1996 Mar; 30(3):181-93. PubMed ID: 8882300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal assessment of a P-glycoprotein-mediated drug interaction of valspodar on digoxin.
    Kovarik JM; Rigaudy L; Guerret M; Gerbeau C; Rost KL
    Clin Pharmacol Ther; 1999 Oct; 66(4):391-400. PubMed ID: 10546923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relative bioavailability of single doses of prolonged-release tacrolimus administered as a suspension, orally or via a nasogastric tube, compared with intact capsules: a phase 1 study in healthy participants.
    Undre N; Dickinson J
    BMJ Open; 2017 Apr; 7(4):e012252. PubMed ID: 28377389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absorption characteristics of a microemulsion formulation of cyclosporine in de novo pediatric liver transplant recipients.
    Dunn SP; Cooney GF; Kulinsky A; Falkenstein K; Pierson A; Elder CA; Meligeni J
    Transplantation; 1995 Dec; 60(12):1438-42. PubMed ID: 8545871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated modelling of the clinical pharmacokinetics of SDZ HTF 919, a novel selective 5-HT4 receptor agonist, following oral and intravenous administration.
    Appel-Dingemanse S; Lemarechal MO; Kumle A; Hubert M; Legangneux E
    Br J Clin Pharmacol; 1999 May; 47(5):483-91. PubMed ID: 10336571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioavailability of repaglinide, a novel antidiabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers.
    Hatorp V; Oliver S; Su CA
    Int J Clin Pharmacol Ther; 1998 Dec; 36(12):636-41. PubMed ID: 9877000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase I/II study of infusional vinblastine with the P-glycoprotein antagonist valspodar (PSC 833) in renal cell carcinoma.
    Bates SE; Bakke S; Kang M; Robey RW; Zhai S; Thambi P; Chen CC; Patil S; Smith T; Steinberg SM; Merino M; Goldspiel B; Meadows B; Stein WD; Choyke P; Balis F; Figg WD; Fojo T
    Clin Cancer Res; 2004 Jul; 10(14):4724-33. PubMed ID: 15269145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.
    Markowitz JS; Straughn AB; Patrick KS; DeVane CL; Pestreich L; Lee J; Wang Y; Muniz R
    Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative pharmacokinetics of two new steroidal estrogens and ethinylestradiol in postmenopausal women.
    Baumann A; Fuhrmeister A; Brudny-Klöppel M; Draeger C; Bunte T; Kuhnz W
    Contraception; 1996 Oct; 54(4):235-42. PubMed ID: 8922877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacogenetic analysis of the absorption kinetics of cyclosporine in a population of Spanish cardiac transplant patients].
    Isla Tejera B; Aumente Rubio MD; Martínez-Moreno J; Reyes Malia M; Arizón JM; Suárez García A
    Farm Hosp; 2009; 33(6):324-9. PubMed ID: 20038391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apparent lack of effect of P-glycoprotein on the gastrointestinal absorption of a substrate, tacrolimus, in normal mice.
    Chiou WL; Chung SM; Wu TC
    Pharm Res; 2000 Feb; 17(2):205-8. PubMed ID: 10751036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.